Non-Hodgkin Lymphomas and CLL
We recommend
![studie_nova_design_novinka_budoucnost](https://www.prolekare.cz/media/cache/resolve/article_list_item_large/media/image/be5dce829662c2ebf1cd403ac92e4108.jpeg)
New Alternative in the Treatment of Diffuse Large B-cell Lymphoma
For patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not suitable candidates for autologous stem cell transplantation, a wide range of treatment regimens is available. Recently, the addition of polatuzumab vedotin to rituximab and bendamustine therapy has shown promising efficacy in both registration studies and real-world clinical practice.
![Spolecnost_soudrznost_spolecne_drzici_se_ruce_sila_pratelstvi](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/1eff0316810b38e9659f569fe042428f.jpeg)
Socio-economic Benefits of Using Obinutuzumab in 1st Line Treatment of Follicular Lymphoma
Pharmacoeconomic analyses remind us that our patients' diseases affect not only themselves or the…
![zhodnocení výsledků vyšetření u lékaře 2356x1571](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/3e7bd738defba275663296e9dc4a13db.jpeg)
FLEX – A New Predictive Model for Assessing Follicular Lymphoma Risks
Overall survival of patients with advanced-stage follicular lymphoma (FL) who experience early…
Articles on this topic
![Lymfom_analýza_krve](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/b286b5389a931c6a4d0c0644955b5ed2.jpeg)
Targeted Treatment and Quality of Life in Patients with Follicular Lymphoma
The GALLIUM clinical trial evaluated chemotherapy in combination with targeted treatment using…
![Medical news](https://www.prolekare.cz/media/cache/resolve/article_list_item_small/media/image/7f4492d30b64dcb6185cd465c9d7b5a4.jpeg)
Polatuzumab Vedotin in the Treatment of NHL - News from the 25th EHA Congress
Polatuzumab vedotin (Polivy) is approved in the EU for the treatment of patients with…
Subscribe
Most read on this topic
Journal on this topic
Related topic
Most read on this topic
- Targeted Treatment and Quality of Life in Patients with Follicular Lymphoma
- Hodgkin´s Lymhoma – the Treatment Aproaches Development and Current Trends
- New Alternative in the Treatment of Diffuse Large B-cell Lymphoma
- FLEX – A New Predictive Model for Assessing Follicular Lymphoma Risks
- Polatuzumab Vedotin in the Treatment of NHL - News from the 25th EHA Congress
- Socio-economic Benefits of Using Obinutuzumab in 1st Line Treatment of Follicular Lymphoma
Journal on this topic
Related topic